Xconomy

Go swimming in the shark tank with Mike Elconin of the San Diego Tech Coast Angels, private investor Ken Olson, Shepherd Ventures managing partner Tom Siegel, and Dennis Clerke of Daggerboard Advisors. In this “open mike night” The San Diego Software Industry Council allows entrepreneurs and company founders to pitch their technologies and startups and … Continue reading “Fly Fishing for Sharks: Inside the Head of a Venture Investor”

Avoid the deal killers and focus on the right priorities in this half-day workshop held by Pete Townsend from the San Diego office of the McDermott Will & Emery law firm. Townsend’s tutorial covers understanding venture funds and how they operate, dealing with VC investors, understanding the stages of VC financing, and common terms of … Continue reading “Learning the Venture Capital Process”

Getting a marketing plan approved solves only part of the challenge that biotech drug developers, medical device, and diagnostic makers face in getting their product distributed and fully commercialized. Developing a strategic market access plan can help reduce perceived risk and uncertainty of commercial success, and add substantially to the asset value of products in … Continue reading “Getting to Market: Adding Value to Your Biomedical Product”

Biocom’s Education Subcommittee, the San Diego Workforce Partnership, Southern California Biotech Center, and San Diego County Office of Education have organized this 6-hour networking event and workshop. Career counselors from K-12, community colleges, four-year schools and one-stop career centers are welcome. Registration is limited to career counselors and related professionals. More information and online registration … Continue reading “7th Annual Life Sciences Career Counseling Workshop”

Biocom is hosting Dave Jones, D-Sacramento, chairman of the California Assembly Health Committee, to its legislative roundtable series. As a comprehensive health reform package continues to take shape in Washington, it is becoming apparent that, if passed, much will be left to individual states to implement. Jones is in a position to have significant influence … Continue reading “Legislative Roundtable With Assemblyman Dave Jones”

As the biotechnology industry faces headwinds due to increased regulatory scrutiny and fewer liquidity events, venture capitalists are insisting that companies provide data from “proof-of-concept” experiments before they consider investing. In addition, once companies receive venture funding, they must move their drug candidates to the clinic with minimal equity capital. Experienced biotech executives and venture … Continue reading “Doing More With Less: Capital Efficiency in Drug Development”

Connect and Blue Mine Group organized this half-day workshop as an introduction to the essentials of designing a successful business model. The presentation includes the five critical elements of a business model and some key tools for optimizing them to maximize potential value. Register online here.

Bluetooth low energy, which consumes a fraction of the power of conventional Bluetooth designs, is the next step in the evolution of Bluetooth wireless technology. As usual, San Diego is a hotbed of activity for this new wireless technology with the R&D operations of several companies based here. Nick Hunn, chairman of the CommNexus Bluetooth … Continue reading “Where to Bluetooth?”

Biocom has organized an all-day seminar for the non-scientist employees of biotech companies, so they can become more instrumental in their company’s success by understanding the science and technology. Be more strategic in your relationship-building by knowing who the industry players are and how they interact. Presentations are given by credentialed biotech instructors. More information … Continue reading “Bio-Briefing for Non-Scientists”

Traditional means of funding private companies in the life science industry have changed forever. Venture capital is no longer a logical choice for raising capital to fund pre-clinical programs, just as it’s no long practical or acceptable to spend vast amounts of cash to advance such research. The San Diego Venture Group has assembled a … Continue reading “Is There Any Way Out of Here? New Ideas for Funding Life Sciences Startups”

With the anniversary of the swine flu outbreak in Mexico approaching in April, San Diego’s Biocom has asked influenza experts to discuss the lessons learned from this pandemic. How did public health agencies from around the world handle the outbreak? How will vaccine production be handled in the future? And what does the biotech industry … Continue reading “Lessons from the Pandemic: H1N1 and the Biotech Industry”